Table 4.
Risk prevention behaviors, access to information on dual contraceptive methods, and related medical factors among the study participants.
| Respondent characteristics | N | (%) | |
|---|---|---|---|
| Ever heard about any f/p methods (n = 545) | Yes | 514 | 94.3 |
| No | 31 | 5.7 | |
| Types of f/p (n = 514) | Injectables | 215 | 41.8 |
| Pills | 93 | 18.1 | |
| Male condom | 68 | 13.2 | |
| Implants | 111 | 21.6 | |
| IUCD | 23 | 4.5 | |
| Tuba ligation | 4 | 0.8 | |
| Source of family planning (n = 514) | ART clinic | 190 | 37 |
| F/P OPD | 287 | 55.9 | |
| Other OPD | 24 | 4.6 | |
| Pharmacy room | 13 | 2.5 | |
| Ever heard about dual f/p methods (n = 514) | Yes | 351 | 68.3 |
| No | 163 | 31.7 | |
| Source of information about dual f/p methods (n = 514) | Mass media | 115 | 22.4 |
| Health professionals | 386 | 75.1 | |
| Friends | 13 | 2.5 | |
| Disclosure to community | No | 471 | 86.4 |
| Yes | 74 | 13.6 | |
| HIV status disclosure to sexual partners (n = 545) | Yes | 456 | 83.7 |
| No | 89 | 16.3 | |
| Discussion with husbands (n = 514) | Yes | 263 | 46.1 |
| No | 251 | 53.9 | |
| HIV sero-status of current sexual partners (n = 383) | Positive | 252 | 65.8 |
| Negative | 41 | 10.7 | |
| Unknown | 90 | 23.5 | |
| CD4 cell count in the last six months (n = 545) | >500 | 306 | 56.1 |
| 350–500 | 156 | 28.6 | |
| <350 | 83 | 15.2 | |
| Current WHO stages | One | 342 | 62.8 |
| Two | 146 | 26.8 | |
| Three | 57 | 10.5 | |